Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name	Market Cap	Price to Earnings TTM	Dividend Yield % TTM
VRDNViridian Therapeutics	$1.18bn	n/a	n/a
AUPHAurinia Pharmaceuticals	$1.17bn	24.23	n/a
MNKDMannKind	$1.14bn	25.37	n/a
EQRXEQRx	$1.14bn	n/a	n/a
NAGENiagen Bioscience	$1.12bn	82.56	n/a
SSIISS Innovations International	$1.12bn	n/a	n/a
DYNDyne Therapeutics	$1.09bn	n/a	n/a
ABCLAbCellera Biologics	$1.08bn	n/a	n/a
OCSOculis Holding AG	$1.08bn	n/a	n/a
CDNACareDx	$1.07bn	n/a	n/a
NVAXNovavax	$1.03bn	2.54	n/a
WVEWave Life Sciences	$1.03bn	n/a	n/a
VERVVerve Therapeutics	$1.01bn	n/a	n/a
CDTXCidara Therapeutics	$997.09m	n/a	n/a
NTLAIntellia Therapeutics	$990.26m	n/a	n/a
GRCLGracell Biotechnologies	$972.69m	n/a	n/a
GERNGeron	$949.01m	n/a	n/a
PSTXPoseida Therapeutics	$927.88m	n/a	n/a
PHVSPharvaris NV	$926.38m	n/a	n/a
SYRESpyre Therapeutics	$918.58m	n/a	n/a